10
Participants
Start Date
May 31, 2004
Primary Completion Date
October 31, 2006
Study Completion Date
October 31, 2006
Glucose clamp technique
euglycemic hyperinsulinemic clamp with target blood glucose of 90 mg/dl (5 mmol/l), followed by hyperglycemic clamp, target blood glucose of 180 mg/dl (10 mmol/l) for measurement of insulin sensitivity and insulin secretion
Amisulpride
Single dose of amisulpride 200 mg p.o. given at 8:00 a.m.
Olanzapine
Single dose of olanzapine 10 mg p.o. given at 8:00 a.m.
Placebo
Placebo capsules are given at 8:00 a.m.
Central Institute of Mental Health, Mannheim
Collaborators (1)
Sanofi
INDUSTRY
Central Institute of Mental Health, Mannheim
OTHER